AU2001264113A1 - Pharmaceutical anti-inflammatory aerosol formulation - Google Patents

Pharmaceutical anti-inflammatory aerosol formulation

Info

Publication number
AU2001264113A1
AU2001264113A1 AU2001264113A AU6411301A AU2001264113A1 AU 2001264113 A1 AU2001264113 A1 AU 2001264113A1 AU 2001264113 A AU2001264113 A AU 2001264113A AU 6411301 A AU6411301 A AU 6411301A AU 2001264113 A1 AU2001264113 A1 AU 2001264113A1
Authority
AU
Australia
Prior art keywords
aerosol formulation
pharmaceutical anti
inflammatory
inflammatory aerosol
pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001264113A
Other languages
English (en)
Inventor
Duncan Robert Armour
David Brown
Miles Stuart Congreve
Paul Martin Gore
Darren Victor Steven Green
Stuart Holman
Torquil Iain Maclean Jack
Andrew Mcmurtrie Mason
Karen Morriss
Nigel Grahame Ramsden
Marian Thomas
Peter Ward
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of AU2001264113A1 publication Critical patent/AU2001264113A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Otolaryngology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
AU2001264113A 2000-06-16 2001-06-15 Pharmaceutical anti-inflammatory aerosol formulation Abandoned AU2001264113A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0014881 2000-06-16
GBGB0014881.7A GB0014881D0 (en) 2000-06-16 2000-06-16 Pharmaceutical aerosol formulation
PCT/GB2001/002613 WO2001095925A1 (fr) 2000-06-16 2001-06-15 Preparation anti-inflammatoire pharmaceutique pour aerosol

Publications (1)

Publication Number Publication Date
AU2001264113A1 true AU2001264113A1 (en) 2001-12-24

Family

ID=9893882

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001264113A Abandoned AU2001264113A1 (en) 2000-06-16 2001-06-15 Pharmaceutical anti-inflammatory aerosol formulation

Country Status (5)

Country Link
EP (1) EP1289539A1 (fr)
JP (1) JP2004503505A (fr)
AU (1) AU2001264113A1 (fr)
GB (1) GB0014881D0 (fr)
WO (1) WO2001095925A1 (fr)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9828074D0 (en) * 1998-12-18 1999-02-17 Glaxo Group Ltd Therapeutically useful compounds

Also Published As

Publication number Publication date
JP2004503505A (ja) 2004-02-05
GB0014881D0 (en) 2000-08-09
EP1289539A1 (fr) 2003-03-12
WO2001095925A1 (fr) 2001-12-20

Similar Documents

Publication Publication Date Title
AU2001224716A1 (en) A medicinal aerosol formulation
AU2001226233A1 (en) A medicinal aerosol formulation
AU781269C (en) Pharmaceutical compositions
AU6310000A (en) Aerosol formulations
AU2001250420A1 (en) Pharmaceutical compositions
AU2001274307A1 (en) Pharmaceutical compositions
AU2002257582A1 (en) Pharmaceutical formulation
AU3556400A (en) Pharmaceutical compositions
AU4328800A (en) Pharmaceutical formulation
AU2002214324A1 (en) Medicinal compositions
AU6715600A (en) Pharmaceutical formulations
AU2001224718A1 (en) A medicinal aerosol formulation
AU2001273919A1 (en) Pharmaceutical compositions
AU2001259318A1 (en) A medicinal aerosol formulation
AU1141101A (en) Pharmaceutical aerosol formulations comprising s-salmeterol
AU4977300A (en) Pharmaceutical formulations
AU4085201A (en) Pharmaceutical composition
AU2002212281A1 (en) Anti-inflammatory active ingredients
AU3839900A (en) Pharmaceutical formulation
AU2001247123A1 (en) A medicinal aerosol formulation
AU2001227531A1 (en) A medicinal aerosol formulation
AU6460100A (en) Pharmaceutical compositions
AU2001264126A1 (en) Pharmaceutical anti-inflammatory aerosol formulation
AU2001274231A1 (en) Novel aqueous anti-inflammatory pharmaceutical formulation
AU2001264129A1 (en) Novel aqueous anti-inflammatory pharmaceutical formulation